GlassScriptPhysician profile
Joseph Decker
NPI 1871940619
$38,014.58
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.53 · 2020: $6.71 · 2021: $534 · 2022: $12K · 2023: $15K · 2024: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $16K · Travel and Lodging: $7,268 · Food and Beverage: $1,768 · Education: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $16,333.00 |
| Travel and Lodging | $7,268.44 |
| Food and Beverage | $1,768.13 |
| Education | $546.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13,809.52 | 2021-2024 | Azure Xt Dr Mri Surescan, Selectsecure, Micra |
| Boston Scientific Corporation | $10,287.24 | 2022-2024 | Watchman Flx, Emblem Mri S-Icd |
| Abbott Laboratories | $7,965.98 | 2021-2024 | Ensite Precision, Ensite |
| Philips North America LLC | $5,826.27 | 2024 | (9520) Igt Devices Undivided, (Bh4) Igt Devices Undivided, (7881) US Und |
| Biosense Webster, INC. | $70.33 | 2023 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.18 | 2019-2020 | |
| Medtronic Vascular, INC. | $21.04 | 2019 | |
| Getinge USA Sales, LLC | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Decker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.